Pages that link to "Q55459247"

The following pages link to Qing Liu (Q55459247):

Displaying 20 items.

• Landmark studies on the glucagon subfamily of GPCRs: from small molecule modulators to a crystal structure (Q26798049) (← links)
• A continued saga of Boc5, the first non-peptidic glucagon-like peptide-1 receptor agonist with in vivo activities (Q27027240) (← links)
• Reversal of obesity and insulin resistance by a non-peptidic glucagon-like peptide-1 receptor agonist in diet-induced obese mice (Q27316004) (← links)
• Histone lysine methyltransferases as anti-cancer targets for drug discovery (Q28076288) (← links)
• A nonpeptidic agonist of glucagon-like peptide 1 receptors with efficacy in diabetic db/db mice (Q33268721) (← links)
• Boc5, a non-peptidic glucagon-like Peptide-1 receptor agonist, invokes sustained glycemic control and weight loss in diabetic mice (Q33358112) (← links)
• Analogues of the Natural Product Sinefungin as Inhibitors of EHMT1 and EHMT2. (Q33636498) (← links)
• Non-peptidic glucose-like peptide-1 receptor agonists: aftermath of a serendipitous discovery (Q33646569) (← links)
• Development of β-amino-carbonyl compounds as androgen receptor antagonists. (Q35160796) (← links)
• High-throughput screening against thioredoxin glutathione reductase identifies novel inhibitors with potential therapeutic value for schistosomiasis (Q35764981) (← links)
• High-throughput screening of antagonists for the orphan G-protein coupled receptor GPR139 (Q36287768) (← links)
• Pharmacological characterization of a novel nonpeptide antagonist for formyl peptide receptor-like 1. (Q40102705) (← links)
• Cycloalkane analogues of sinefungin as EHMT1/2 inhibitors (Q50873698) (← links)
• W2476 ameliorates β-cell dysfunction and exerts therapeutic effects in mouse models of diabetes via modulation of the thioredoxin-interacting protein signaling pathway. (Q51002471) (← links)
• Human substance P receptor binding mode of the antagonist drug aprepitant by NMR and crystallography (Q61798028) (← links)
• Cyclobutane derivatives as novel nonpeptidic small molecule agonists of glucagon-like peptide-1 receptor (Q82608507) (← links)
• A Guanidine-Based Synthetic Compound Suppresses Angiogenesis via Inhibition of Acid Ceramidase (Q90208440) (← links)
• Adenine derivatives invert high glucose-induced thioredoxin-interacting protein overexpression (Q90458876) (← links)
• Structural basis of peptidomimetic agonism revealed by small- molecule GLP-1R agonists Boc5 and WB4-24 (Q112558364) (← links)
• Molecular insights into ago-allosteric modulation of the human glucagon-like peptide-1 receptor (Q112582961) (← links)